These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2645177)

  • 1. Clinical distribution of anticentromere antibody in Japanese patients.
    Soma Y; Takehara K; Ishibashi Y
    Dermatologica; 1989; 178(1):16-9. PubMed ID: 2645177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal study of patients with anticentromere antibody.
    Takehara K; Soma Y; Igarashi A; Kikuchi K; Tamaki T; Ishibashi Y
    Dermatologica; 1990; 181(3):202-6. PubMed ID: 2135387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical spectrum of patients with anticentromere antibodies].
    Insua Vilariño S; de la Hera Martínez M; Rodríguez-Valverde V; Merino Pérez J; Alonso Valdivieso JL; Ruiz T
    Rev Clin Esp; 1993 Apr; 192(6):260-4. PubMed ID: 8497719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticentromere antibody in localized scleroderma.
    Ruffatti A; Peserico A; Glorioso S; Fiocco U; Rossi L; Gambari P; Todesco S
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 1):637-42. PubMed ID: 3534010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticentromere and anticentriole antibodies in the scleroderma spectrum.
    Tuffanelli DL; McKeon F; Kleinsmith DM; Burnham TK; Kirschner M
    Arch Dermatol; 1983 Jul; 119(7):560-6. PubMed ID: 6859899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease.
    Goldman JA
    Ann Rheum Dis; 1989 Sep; 48(9):771-5. PubMed ID: 2802800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Generalized morphea-like progressive systemic sclerosis with anticentromere antibodies and eosinophilic cellulitis].
    Sasaki T; Nakajima H; Kameda Y
    Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(4):469-76. PubMed ID: 2614990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raynaud's phenomenon, anticentromere antibodies, and digital necrosis without sclerodactyly: an entity independent of scleroderma?
    Sachsenberg-Studer EM; Prins C; Saurat JH; Salomon D
    J Am Acad Dermatol; 2000 Oct; 43(4):631-4. PubMed ID: 11004618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants.
    McCarty GA; Rice JR; Bembe ML; Barada FA
    Arthritis Rheum; 1983 Jan; 26(1):1-7. PubMed ID: 6337593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
    Fritzler MJ; Kinsella TD
    Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of anticentromere antibody assay].
    Moteki S
    Nihon Rinsho; 1990 Feb; 48 Suppl():580-3. PubMed ID: 2192153
    [No Abstract]   [Full Text] [Related]  

  • 13. The anticentromere antibody: disease specificity and clinical significance.
    Powell FC; Winkelmann RK; Venencie-Lemarchand F; Spurbeck JL; Schroeter AL
    Mayo Clin Proc; 1984 Oct; 59(10):700-6. PubMed ID: 6384675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The titers and complement-activating abilities of anticentromere antibody in systemic sclerosis, other connective tissue diseases, and other related conditions].
    Sato S; Takehara K; Ishibashi Y
    Nihon Hifuka Gakkai Zasshi; 1991 Feb; 101(2):97-104. PubMed ID: 2072581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heterogeneity of anticentromere antibodies in immunoblotting analysis.
    Muro Y; Sugimoto K; Okazaki T; Ohashi M
    J Rheumatol; 1990 Aug; 17(8):1042-7. PubMed ID: 2213779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
    Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
    Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological markers in progressive systemic sclerosis: clinical correlations.
    Catoggio LJ; Bernstein RM; Black CM; Hughes GR; Maddison PJ
    Ann Rheum Dis; 1983 Feb; 42(1):23-7. PubMed ID: 6402991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of anticentromere antibody in idiopathic Raynaud's syndrome.
    Sarkozi J; Bookman AA; Lee P; Keystone EC; Fritzler MJ
    Am J Med; 1987 Nov; 83(5):893-8. PubMed ID: 3314499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.
    Kallenberg CG; Pastoor GW; Wouda AA; The TH
    Ann Rheum Dis; 1982 Aug; 41(4):382-7. PubMed ID: 7051989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Raynaud's phenomenon and anti-centromeric antibodies].
    Marquet R; Villar MM; Ordi J; de la Figuera M; Vilardell M
    Med Clin (Barc); 1984 Jun; 83(3):129-30. PubMed ID: 6482556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.